Dr.Reddy's Laboratories Ltd (REDY.BO) Company Profile | Reuters.com
Edition:
United States

Profile: Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

3,265.75INR
28 Jun 2016
Change (% chg)

Rs25.10 (+0.77%)
Prev Close
Rs3,240.65
Open
Rs3,240.55
Day's High
Rs3,282.80
Day's Low
Rs3,236.05
Volume
35,402
Avg. Vol
31,891
52-wk High
Rs4,382.95
52-wk Low
Rs2,750.00

Dr. Reddy's Laboratories Limited is an integrated global pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Global Generics segment consists of its business of manufacturing and marketing prescription and over-the-counter (OTC) finished pharmaceutical products, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients (API) and intermediates. Proprietary Products segment consists of its differentiated formulations business, its new chemical entities (NCEs) business and its dermatology focused specialty business. The Company's OTC brands include Doan's, Bufferin, Nupercainal Ointment, Cruex Nail Gel, Comtrex and Myoflex.

Company Address

Dr.Reddy's Laboratories Ltd

8-2-337, Road No.3, Banjara Hill
HYDERABAD     500034
P: +9140.49002900
F: +9140.49002999

Company Web Links